Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases. The company is dedicated to educating ...

At least one-third of the world's population has been infected with the hepatitis B virus (HBV), and 400 million people are chronic carriers. In most populations, chronic HBV infection is the ...

The hepatitis B virus infects liver cells and is not to be confused with other types of hepatitis viruses, including the better known hepatitis A and C. The virus is spread by bodily fluids ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...

Currently, we are focused on the hepatitis B virus capsid, the cytoplasmic dynein motor domain, and the role of carbohydrates and glycoconjugates in immunity and disease. "Assembly properties of ...

Unlike inactivated, subunit or recombinant protein vaccines (such as those against diphtheria, pertussis, tetanus, hepatitis B virus and flu ... for the capsid protein P1, was recoded with ...